Injective (INJ) is currently priced at $4.70, reflecting a modest 2.40% increase over the last 24 hours. The daily price movement shows a range between $4.51 and $4.74, indicating a stable trading environment with a daily range of 0.23%.

Volume for the past 24 hours stands at approximately 38.36 million, representing 8.16% of the market cap, which signals healthy trading activity. The short-term moving averages indicate a slight bullish trend, with the 8 SMA at $4.64 reflecting a 1.23% increase and the 13 SMA at $4.62 showing a 1.65% increase.

However, longer-term trends reveal potential weaknesses, as the 7-day RSI is at 46, suggesting the asset is nearing oversold territory. Furthermore, the 14-day price change of -16.98% and the 30-day price change of -14.82% indicate a negative trend over a longer period, which may affect investor sentiment.

Despite the recent positive shift, the asset's current price is significantly lower than its all-time high of $52.62, achieved in March 2024. This stark contrast highlights the need for caution, as the price has not shown recovery signs in the medium to long term.

In conclusion, while the short-term indicators show some positive momentum, the overall trend remains bearish. Given the mixed signals from the RSI and the longer-term price performance, the recommendation for Injective (INJ) is to Hold, as potential upward momentum may be fleeting without a solid reversal in the overall trend.